ICYMI, this week we had news about VENT-03's potential as a small molecule therapeutic in dermatology, a permanent J-code for the first and only FDA-approved treatment for molluscum contagiosum, and more.
Let us know if you plan to attend IMCAS World Congress 2024.
Topical antifungals, whether FDA-approved or available over-the-counter, exhibited more effective penetration through cellulose disks than cadaver nails.
Marcelo Bigal, MD, PhD, discusses VENT-03's potential as a small molecule therapeutic in dermatology, among other fields.
The Centers for Medicare & Medicaid Services has issued a permanent J-code for the first and only FDA-approved treatment for molluscum contagiosum.
An immunosuppressed patient with refractory plantar warts showed improvement following cantharidinpodophyllotoxin-salicylic acid (CPS) monotherapy.
Patients with chronic spontaneous urticaria saw improvement in itch and hive severity when dupilumab was added to their antihistamines in a 24-week study.
Learn more about the in-depth topics covered in the January 2024 topical treatments for vitiligo supplement of Dermatology Times.
Among the many sessions to be held at the IMCAS World Congress 2024 in Paris, France, several Dermatology Times Editorial Advisory Board members are preparing to share their knowledge and insights.
Functional magnetic resonance imaging response was utilized to test motor, somatosensory association cortex, perception, and sensory integration processing in a recent study.
People with vitiligo face a higher risk of retinal detachment, according to a study in Taiwan.
Positive results in preclinical animal trials of DPT0218 may lead to advances in clinical treatment of autoimmune diseases.
Learn more about the in-depth topics covered in the January 2024 print issue of Dermatology Times.
Dermatology Times is looking back on the top stories in dermatology from the month of January.
The 3-year partnership and collaboration will employ the use of generative artificial intelligence and analytics technologies.
Dermatology Times is recapping our top expert interviews from the month of January.
Ablon’s session highlights include best practices for hair restoration.
A new report looking at melanoma in Black patients adds much-needed clinical insights.
An OTC moisturizer was found to improve skin ceramide levels in patients with eczema-prone skin.
Dermatology Times asked our readers to share what conferences they are looking forward to in the first quarter of 2024.
LC-OCT demonstrated higher sensitivity and negative predictive value compared to other methods of diagnosis and detection.
Researchers in China reviewed topical modalities, minoxidil solutions, tofacitinib, and microneedling for pediatric AA.
People with vitiligo in the US face burdensome health care expenses, including expenses seemingly unrelated to the condition, according to 1 study.
Researchers have identified an epigenetic pathway involved in resistance to mitogen-activated protein kinase inhibitors, pointing the way to better patient treatment for resistant melanomas.
In a review of relevant research, investigators found that in many aspects, telemedicine services were as effective as in-office care visits for AD.
The guidelines update the American Academy of Dermatology’s 2016 recommendations for acne management in adults, adolescents, and children aged 9 and older.
Although new equipment can enhance the capabilities and profitability of a dermatology practice, the decision to make such an investment is a significant one.
Compared with cartridge razors, safety razors demonstrated a lower incidence of erythema.
To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.